| Product Code: ETC4756148 | Publication Date: Nov 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The Mauritius Ophthalmic Drugs Market is projected to witness mixed growth rate patterns during 2025 to 2029. Starting at 9.46% in 2025, the market peaks at 10.92% in 2027, and settles at 3.65% by 2029.

By 2027, the Ophthalmic Drugs market in Mauritius is anticipated to reach a growth rate of 10.92%, as part of an increasingly competitive Africa region, where Egypt remains at the forefront, supported by South Africa, Ethiopia, Algeria and Nigeria, driving innovations and market adoption across sectors.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Ophthalmic Drugs Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Ophthalmic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius Ophthalmic Drugs Market - Industry Life Cycle |
3.4 Mauritius Ophthalmic Drugs Market - Porter's Five Forces |
3.5 Mauritius Ophthalmic Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Mauritius Ophthalmic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Mauritius Ophthalmic Drugs Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.8 Mauritius Ophthalmic Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Mauritius Ophthalmic Drugs Market Revenues & Volume Share, By Therapeutic Class, 2021 & 2031F |
4 Mauritius Ophthalmic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mauritius Ophthalmic Drugs Market Trends |
6 Mauritius Ophthalmic Drugs Market Segmentations |
6.1 Mauritius Ophthalmic Drugs Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Dry Eye, 2021-2031F |
6.1.3 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Glaucoma, 2021-2031F |
6.1.4 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Infection/Inflammation/Allergy, 2021-2031F |
6.1.5 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Retinal Disorders, 2021-2031F |
6.1.6 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.2 Mauritius Ophthalmic Drugs Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Prescription Drugs, 2021-2031F |
6.2.3 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Over-the-counter Drugs, 2021-2031F |
6.3 Mauritius Ophthalmic Drugs Market, By Dosage Form |
6.3.1 Overview and Analysis |
6.3.2 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Liquid Ophthalmic Drug Forms, 2021-2031F |
6.3.3 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Solid Ophthalmic Drug Forms, 2021-2031F |
6.3.4 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Semisolid Ophthalmic Drug Forms, 2021-2031F |
6.3.5 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Multicompartment Drug Delivery Systems, 2021-2031F |
6.3.6 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Other Ophthalmic Drug Forms, 2021-2031F |
6.4 Mauritius Ophthalmic Drugs Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.4.3 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Drug Stores, 2021-2031F |
6.4.4 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
6.4.5 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.5 Mauritius Ophthalmic Drugs Market, By Therapeutic Class |
6.5.1 Overview and Analysis |
6.5.2 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Anti-glaucoma, 2021-2031F |
6.5.3 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Anti-infection, 2021-2031F |
6.5.4 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Anti-inflammation, 2021-2031F |
6.5.5 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Anti-allergy, 2021-2031F |
6.5.6 Mauritius Ophthalmic Drugs Market Revenues & Volume, By Others, 2021-2031F |
7 Mauritius Ophthalmic Drugs Market Import-Export Trade Statistics |
7.1 Mauritius Ophthalmic Drugs Market Export to Major Countries |
7.2 Mauritius Ophthalmic Drugs Market Imports from Major Countries |
8 Mauritius Ophthalmic Drugs Market Key Performance Indicators |
9 Mauritius Ophthalmic Drugs Market - Opportunity Assessment |
9.1 Mauritius Ophthalmic Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Mauritius Ophthalmic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Mauritius Ophthalmic Drugs Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.4 Mauritius Ophthalmic Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Mauritius Ophthalmic Drugs Market Opportunity Assessment, By Therapeutic Class, 2021 & 2031F |
10 Mauritius Ophthalmic Drugs Market - Competitive Landscape |
10.1 Mauritius Ophthalmic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Mauritius Ophthalmic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here